Chikungunya outbreak in Guangdong Province, China, 2010.
Subject: Epidemics (China)
Epidemics (Indian Ocean)
Epidemics (Health aspects)
Epidemics (Analysis)
Infection (Health aspects)
Infection (Analysis)
Authors: Wu, De
Wu, Jie
Zhang, Qiaoli
Zhong, Haojie
Ke, Changwen
Deng, Xiaoling
Guan, Dawei
Li, Hui
Zhang, Yonghui
Zhou, Huiqiong
He, Jianfeng
Li, Linghui
Yang, Xingfen
Pub Date: 03/01/2012
Publication: Name: Emerging Infectious Diseases Publisher: U.S. National Center for Infectious Diseases Audience: Academic; Professional Format: Magazine/Journal Subject: Health Copyright: COPYRIGHT 2012 U.S. National Center for Infectious Diseases ISSN: 1080-6040
Issue: Date: March, 2012 Source Volume: 18 Source Issue: 3
Geographic: Geographic Scope: China; Indian Ocean Geographic Code: 9CHIN China; 0INDI Indian Ocean
Accession Number: 283455636
Full Text: Chikungunya virus (CHIKV) is a mosquito-borne virus that causes fever, headache, rash, nausea, vomiting, myalgia, and arthralgia, and has had a major effect on human health (1,2). The first human infections caused by CHIKV were reported [approximately equal to] 60 years ago (1952-1953) in eastern Africa (3). CHIKV has now become a worldwide public health problem. Although this virus is indigenous to tropical Africa, outbreaks of CHIKV fever have been reported in countries in the Indian Ocean region and Southeast Asia (4-6). With an increase in global travel, the risk for spreading CHIKV to regions in which the virus is not endemic has increased (7).

Multiple sporadic cases of nonindigenous CHIKV infection have been reported in China. In 1987, CHIKV was isolated from the serum of a patient, and antibodies against CHIKV were detected in a second, convalescent-phase patient in Yunnan Province (8). Four imported case of CHIKV infection confirmed by reverse transcription PCR (RT-PCR) were detected in Guangzhou and Moming, Guangdong Province, in travelers returning from Sri Lanka and Malaysia in 2008 (9,10). Another imported case from India was confirmed by using RT-PCR in our laboratory in 2009. We report an outbreak of CHIKV fever that occurred in Guangdong Province, China, in 2010.

The Study

Guangdong Province is located in a subtropical zone. It has a high relative humidity, an average yearly temperature of 19[degrees]C-24[degrees]C, and an average yearly rainfall of 1,300-2,500 mm. Aedes albopictus mosquitoes are abundant and widespread. However, Ae. aegypti mosquitoes are found only in western Guangdong Province and not in the region around the city of Dongguan. In the months before the outbreak, the weather in Guangdong Province was particularly rainy.

During September 2010, patients reporting an illness with dengue-like symptoms were recorded by local community clinics in the suburbs of Dongguan, Guangdong Province. For epidemiologic investigation, the Guangdong Center for Disease Control and Prevention defined a clinical case of CHIK fever as a case characterized by sudden onset of fever with arthralgia, maculopapular rash, or myalgia. We identified 173 patients (74 male and 99 female patients) 2-93 years of age in 2 adjacent villages who had similar symptoms. More than 85% of the patients were found in these 2 villages in 97 families (>2 cases per family in 50 families).

The first patient became ill on September 1, and the number of CHIKV fever cases rapidly increased after September 19 (Figure 1), indicating an outbreak of CHIKV infections in the region. The outbreak spanned 2 months, and the peak occurred at the end of September/early October. None of the patients or any family members reported travel abroad since July 2010. No deaths were reported as a result of the outbreak, and most patients recovered within 1 week after onset of symptoms. No patients were hospitalized; however, several elderly patients reported joint pain after 2 weeks.

Densities of Ae. albopictus mosquitoes were investigated during the outbreak, and an especially high Breteau index of 77-180 was observed. The abundant rainfall likely resulted in an extremely high mosquito density. To control the outbreak, mosquito control measures were implemented and quarantine of patients with acute disease was enforced.

To identify the pathogen causing the outbreak, we collected 15 serum samples from 12 patients with acute disease and 3 patients with convalescent-phase disease who had dengue-like symptoms. Patient serum was assayed for CHIKV nucleic acid, antibody, and virus. DNA sequence analysis of amplified CHIKV envelope 1 (E1) was performed to infer possible source of transmission. Specimens were tested by real-time RT-PCR for CHIKV (11) and dengue virus.

Ten serum samples were positive for CHIKV. Virus-specific IgM and IgG were detected by IgM and IgG capture ELISAs (IBL, Hamburg, Germany). Seven samples were positive for IgM and 1 sample was positive for IgG (Table). There were 3 case-patients in whom CHIKV nucleic acid and antibody were found at the same time; 2 of these were in serum samples obtained 3-4 days after these samples were found to be positive for CHIKV IgM. We infer that high cross-reactivity in the ELISAs might contribute to these results.

[FIGURE 1 OMITTED]

For phylogenetic analysis, RT-PCR was performed as described (12), and 7 amplicons were sequenced. The 10 nucleic acid-positive specimens were placed on C6/36 and BHK-21 cell lines to isolate CHIKV. Serum samples were 2-fold serially diluted 6 times (1:50-1:1,600) in minimal essential medium, and 1 mL of diluted sample was added to each well of a 24-well culture plate. Specimens were incubated at 33[degrees]C in an atmosphere of 5% C[O.sub.2] and observed daily for [greater than or equal to] 7 days for cytopathic effects (CPEs) (online Appendix Figure, wwwnc.cdc.gov/EID/ article/18/3/11-0034-FA1.htm). After specimens were incubated for 4-7 days, 3 CPEs were observed on C6/36 and BHK-21 cells. Development of CPEs in C6/36 cells is unusual for CHIKV. However, we observed the effect of C6/36 cell fusion on 3 specimens. We speculate that a virus mutation causes an increase in virulence or changes effects on infected C6/36 cells.

Phylogenetic analysis was performed for partial E1 sequences (7 from this study and 24 from GenBank) by using MEGA5 (13). Nucleotide sequences were separated into 3 subgroups corresponding to the 3 globally circulating subgroups (Figure 2). Sequences of the 7 PCR products obtained in this study showed few differences from each other. Paired sequence identity ranged from 98% to 99% at the nucleotide level. Genetic analysis of the 325-nt fragment of E1 genes obtained in this study showed that all 7 sequences clustered in a unique branch within the Indian Ocean clade of the East/Central/South African (ECSA) genotype, and close to Thailand (GQ870312, FJ882911, GU301781), Malaysia (FJ998173), Taiwan (FJ807895), and China (GU199352, GU199353) isolates (98%-99%). The translated E1 gene fragment from 1 of the 7 isolates in this study (China/GD112/2010) had an expected 2-codon deletion. This deletion was also present in the ESCA clade but was not found in the other 6 isolates.

On the basis of sequence analysis, the highest degree of identity was observed with outbreak isolates and the E1 sequence from the Thailand strain (FJ882911) isolated in 2009. Paired identity values were 99% at the nucleotide level and 100% at the amino acid level. Nucleotide substitute analysis showed that a common nucleotide substitution was observed at partial E1 gene site 250 (T'C) in outbreak isolates and FJ882911. This substitution was not observed in other analyzed sequences from GenBank. These results suggested that the virus causing this outbreak was likely transmitted from a source in Southeast Asia and probably evolved from a strain that originated in Thailand.

[FIGURE 2 OMITTED]

Conclusions

CHIKV was not endemic to China before 2010. However, in recent years, CHIKV strains from Southeast Asia with the ECSA genotype have been transmitted by infected persons to Guangdong Province. We report an outbreak of CHIKV fever in China. The low severity of the disease and misdiagnosis of dengue fever has likely encouraged widespread transmission of the virus. High-density mosquito populations and an immunologically uninfected population were 2 contributing factors in this outbreak.

Acknowledgments

We thank Corina Monagin, John Klena, Jay Varma, and Shuyu Wu for assistance in revising the manuscript.

This study was partly supported by the National Science Foundation, Guangdong Detection Research Center on Emerging Infectious Disease Response, and Technical Research and Development Item of Guangdong (2062499).

Dr De Wu is a research scientist at the Guangdong Center for Disease Control and Prevention, Guangdong, China. His research interests are detection and epidemiology of arboviruses.

References

(1.) Cavrini F, Gaibani P, Pierro AM, Rossini G, Landini MP, Sambri V. Chikungunya: an emerging and spreading arthropod-borne viral disease. J Infect Dev Ctries. 2009;3:744-52.

(2.) Thiboutot MM, Kannan S, Kawalekar OU, Shedlock DJ, Khan AS, Sarangan G, et al. Chikungunya: a potentially emerging epidemic? PLoS Negl Trop Dis. 2010;4:e623. http://dx.doi.org/10.1371/journal. pntd.0000623

(3.) Sudeep AB, Parashar D. Chikungunya: an overview. J Biosci. 2008;33:443-9. http://dx.doi.org/10.1007/s12038-008-0063-2

(4.) Kaur P, Ponniah M, Murhekar MV, Ramachandran V, Ramachandran R, Raju HK, et al. Emerg Infect Dis. 2008;14:1623-5. http:// dx.doi.org/10.3201/eid1410.070569

(5.) Leo YS, Chow AL, Tan LK, Lye DC, Lin L, Ng LC. Chikungunya outbreak, Singapore,2008. Emerg Infect Dis. 2009;15:836-7. http:// dx.doi.org/10.3201/eid1505.081390

(6.) Arguin PM, Marano N, Freedman DO. Globally mobile populations and the spread of emerging pathogens. Emerg Infect Dis. 2009;15:1713-4.

(7.) Enserink M. Entomology. A mosquito goes global. Science. 2008;320:864-6. http://dx.doi.org/10.1126/science.320.5878.864

(8.) Huang WL, Zhang HL, Mi ZQ, Shi HF, Bao MH, Qian XY. Some animals' susceptibility to Yunnan CHIK virus. Journal of Dali Medical College. 1998;7:12-5.

(9.) Zheng K, Li J, Zhang Q, Liang M, Li C, Lin M, et al. Genetic analysis of chikungunya viruses imported to mainland China in 2008. Virol J. 2010;7:8. http://dx.doi.org/10.1186/1743-422X-7-8

(10.) Wu JY, Lun ZR, James AA, Chen XG. Dengue fever in mainland China. Am J Trop Med Hyg. 2010;83:664-71. http://dx.doi. org/10.4269/ajtmh.2010.09-0755

(11.) Huang JC, Zheng K, Li XB, Hong Y, Shi YX. Xing LQ, et al. Study on real-time RT-PCR detection method for chikungunya virus. Chinese Journal of Health Laboratory Technology. 2008;18:1721-3.

(12.) Theamboonlers A, Rianthavorn P, Praianantathavorn K, Wuttirattanakowit N, Poovorawan Y. Clinical and molecular characterization of chikungunya virus in south Thailand. Jpn J Infect Dis. 2009;62:303-5.

(13.) Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731-9. http://dx.doi.org/10.1093/ molbev/msr121

Author affiliations: Center for Disease Control and Prevention, Guangdong, China (D. Wu, J. Wu, D. Zhong, C. Ke, X. Deng, D. Guan, H. Li, Y. Zhang, H. Zhou, J. He, L. Li, X. Yang); and Dongguan Center for Disease Control and Prevention, Dongguan, China (Q. Zhang)

DOI:http://dx.doi.org/ 10.3201/eid1803.110034

Address for correspondence: Changwen Ke, Emerging Infectious Diagnosis Center, Guangdong Center for Disease Control and Prevention, 176 Xin Gang Xi Rd West, Guangzhou, People's Republic of China; email: kecw1965@yahoo.com.cn
Table. Characteristics of case-patients and serum sample detection for
chikungunya virus, Guangdong, China, 2010 *

                                          Signs and symptoms
Case-                   Date of
patient ID   Age,    symptom onset,            Red
no.          y/sex      Sep 2010      Fever   face    Headache

D10112       33/F          27           +       -        -
D10113        7/M          29           +       +        -
D10114       62/M          30           +       +        +
D10115       48/F          30           +       -        -
D10116       60/M          28           +       -        -
D10117       39/M          27           +       +        -
D10118f      59/M          19           +       +        -
D10119       59/F          26           -       +        -
D10120       10/F          26           +       -        +
D10121f      56/F          21           +       +        -
D10122f      24/F          21           +       +        -
D10123        3/F          26           +       -        -
D10124       60/M          26           +       -        -
D10125       60/F          29           +       -        -
D10126       39/M          28           +       -        -

                 Signs and symptoms
Case-
patient ID
no.          Arthralgia   Myalgia   MR

D10112           +           +       +
D10113           +           +       +
D10114           +           -       -
D10115           +           -       +
D10116           +           +       -
D10117           +           +       +
D10118f          +           -       +
D10119           +           -       +
D10120           -           -       +
D10121f          +           -       +
D10122f          +           +       +
D10123           -           -       +
D10124           +           +       +
D10125           +           +       +
D10126           +           +       +

                         Test results
Case-
patient ID     Virus     Real-time RT-   IgM/
no.          isolation    PCR/RT-PCR     IgG

D10112           -            +/+        -/-
D10113           +            +/+        -/-
D10114           +            +/+        -/-
D10115           +            +/+        -/-
D10116           -            +/-        -/-
D10117           -            +/-        +/-
D10118f         ND           -/ND        +/+
D10119          ND           -/ND        -/-
D10120          ND           -/ND        +/-
D10121f         ND           -/ND        +/-
D10122f         ND           -/ND        +/-
D10123           -            +/-        -/-
D10124           -            +/+        -/-
D10125           -            +/+        +/-
D10126           -            +/+        +/-

* All samples were obtained on October 1, 2010. ID, identification;
MR, maculopapular rash; RT-PCR, reverse transcription PCR; +,
positive; -, negative; ND, not done.

([dagger]) Convalescent-phase case-patient.
Gale Copyright: Copyright 2012 Gale, Cengage Learning. All rights reserved.